- Citado por SciELO
- Citado por Google
- Similares em SciELO
- Similares em Google
Revista da Sociedade Brasileira de Medicina Tropical
versão impressa ISSN 0037-8682
REITER, Keli Cristine; MACHADO, Alice Beatriz Mombach Pinheiro; FREITAS, Ana Lúcia Peixoto de e BARTH, Afonso Luís. High prevalence of methicillin-resistant Staphylococcus aureus with SCCmec type III in cystic fibrosis patients in southern, Brazil. Rev. Soc. Bras. Med. Trop. [online]. 2010, vol.43, n.4, pp. 377-381. ISSN 0037-8682. http://dx.doi.org/10.1590/S0037-86822010000400008.
INTRODUCTION: Bacterial colonization of the lungs is the main cause of morbidity in cystic fibrosis (CF). Pathogens such as Staphylococcus aureus are very well adapted to the pulmonary environment and may persist for years in the same patient. Genetic determinants of these bacteria, such as the presence of SCCmec have recently emerged as a problem in this population of patients. METHODS: Staphylococcus aureus isolates obtained from different clinical materials coming from CF and non-CF patients attended at a cystic fibrosis reference hospital were compared according to SCCmec type and antibiotic susceptibility profile. RESULTS: Three hundred and sixty-four single-patient Staphylococcus aureus isolates were collected, of which 164 (45%) were from CF patients. Among the latter, 57/164 (44.5%) were MRSA, and among the non-CF patients, 89/200 (35%) were MRSA. Associated pathogens were found in 38 CF patients. All 57 MRSA from CF patients harbored the multiresistant cassette type III. In contrast, 31/89 MRSA from non-CF patients harbored SCCmec type I (35%) and 44/89 harbored type III (49%). The antibiotic susceptibility pattern was similar between CF and non-CF patients. CONCLUSIONS: The high prevalence of multiresistant SCCmec type III among CF patients compared with non-CF patients in our institution may make it difficult to control disease progression through antibiotic therapy for promoting the survival of this kind of patient.
Palavras-chave : Cystic fibrosis; SCCmec; MRSA; Multiresistance.